COVID–19 Access to Testing and Support for Immune Response Research Act of 2021

Bill 117 hr 5745, also known as the COVID–19 Access to Testing and Support for Immune Response Research Act of 2021, aims to provide funding and support for research related to COVID-19 testing and immune response. The bill focuses on increasing access to testing for the virus and supporting research efforts to better understand how the immune system responds to COVID-19.

The bill includes provisions for funding research on new testing methods and technologies, as well as supporting the development of treatments and vaccines for COVID-19. It also aims to improve coordination between federal agencies, healthcare providers, and researchers to ensure a more effective response to the pandemic.

Additionally, the bill includes measures to increase access to testing for underserved communities and populations that have been disproportionately affected by COVID-19. This includes funding for community-based testing sites and outreach programs to ensure that everyone has access to testing and treatment. Overall, the COVID–19 Access to Testing and Support for Immune Response Research Act of 2021 seeks to improve the nation's response to the COVID-19 pandemic by increasing access to testing, supporting research efforts, and ensuring that all communities have access to the resources they need to combat the virus.